S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
BREAKING: Tiny biotech successfully treats blindness (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Stock market today: Global shares mostly decline, while Tokyo again finishes at a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
BREAKING: Tiny biotech successfully treats blindness (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Stock market today: Global shares mostly decline, while Tokyo again finishes at a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
BREAKING: Tiny biotech successfully treats blindness (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Stock market today: Global shares mostly decline, while Tokyo again finishes at a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
BREAKING: Tiny biotech successfully treats blindness (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Stock market today: Global shares mostly decline, while Tokyo again finishes at a record high
AT&T will give $5 to customers hit by cellphone network outage
NASDAQ:BBLG

Bone Biologics (BBLG) Stock Price, News & Analysis

$3.60
0.00 (0.00%)
(As of 02/23/2024 08:52 PM ET)
Today's Range
$3.25
$3.69
50-Day Range
$2.93
$6.00
52-Week Range
$2.86
$86.81
Volume
22,300 shs
Average Volume
100,681 shs
Market Capitalization
$1.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Bone Biologics MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.95% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.36mentions of Bone Biologics in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($25.84) to ($29.84) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.64 out of 5 stars


BBLG stock logo

About Bone Biologics Stock (NASDAQ:BBLG)

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

BBLG Stock Price History

BBLG Stock News Headlines

See More Headlines
Receive BBLG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/25/2024
Next Earnings (Estimated)
4/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:BBLG
Previous Symbol
NASDAQ:BBLG
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Net Income
$-1,490,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$5.44 per share

Miscellaneous

Free Float
465,000
Market Cap
$1.91 million
Optionable
Not Optionable
Beta
0.29
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report














BBLG Stock Analysis - Frequently Asked Questions

How have BBLG shares performed in 2024?

Bone Biologics' stock was trading at $4.52 on January 1st, 2024. Since then, BBLG stock has decreased by 20.4% and is now trading at $3.60.
View the best growth stocks for 2024 here
.

Are investors shorting Bone Biologics?

Bone Biologics saw a decline in short interest in the month of January. As of January 31st, there was short interest totaling 10,400 shares, a decline of 75.4% from the January 15th total of 42,300 shares. Based on an average daily volume of 315,600 shares, the short-interest ratio is presently 0.0 days. Currently, 2.0% of the company's stock are sold short.
View Bone Biologics' Short Interest
.

When is Bone Biologics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 4th 2024.
View our BBLG earnings forecast
.

When did Bone Biologics' stock split?

Bone Biologics's stock reverse split on Wednesday, December 20th 2023. The 1-8 reverse split was announced on Wednesday, December 20th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, December 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

When did Bone Biologics IPO?

(BBLG) raised $8 million in an initial public offering on Wednesday, October 13th 2021. The company issued 1,510,455 shares at a price of $5.25 per share.

How do I buy shares of Bone Biologics?

Shares of BBLG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BBLG) was last updated on 2/26/2024 by MarketBeat.com Staff